OTC Markets OTCPK - Delayed Quote USD
Basilea Pharmaceutica AG (BPMUF)
47.50
-3.50
(-6.86%)
At close: April 22 at 12:17:24 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 6 | 4 |
| Avg. Estimate | -- | -- | 217.58M | 256.91M |
| Low Estimate | -- | -- | 201M | 228.21M |
| High Estimate | -- | -- | 223.9M | 278.7M |
| Year Ago Sales | -- | -- | 208.5M | 217.58M |
| Sales Growth (year/est) | -- | -- | 4.35% | 18.08% |
EPS Trend
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| BPMUF | -- | -- | -- | -- |
| S&P 500 | 13.08% | 2.48% | 7.55% | 13.96% |
Related Tickers
IDIA.SW Idorsia Ltd
1.6420
+5.94%
GUTS Fractyl Health, Inc.
1.9000
0.00%
ACLX Arcellx, Inc.
62.06
-2.54%
ASND Ascendis Pharma A/S
162.84
-0.45%
BTAI BioXcel Therapeutics, Inc.
1.1800
-4.07%
OTLK Outlook Therapeutics, Inc.
1.8400
+2.22%
NLSP NLS Pharmaceutics AG
2.2000
-5.98%
ZEAL.CO Zealand Pharma A/S
453.50
-0.83%
HALO Halozyme Therapeutics, Inc.
56.07
+2.45%
VRNA Verona Pharma plc
81.20
+4.79%